Liver function of Streptozotocin- Induced Diabetic Rats Orally Administered Aqueous Root-Bark Extracts of <i>Tetrapleura tetraptera</i> (Taub).

Abstract

The aqueous root-bark extract of Tetrapleura tetraptera Taub. has been shown to  ameliorate streptozotocin (STZ)-induced hyperglycaemia and dyslipidaemia. This study evaluated the liver status of STZ- induced diabetic rats treated with aqueous root-bark extract of T. tetraptera for 35 days. Twenty-four (24) rats in four groups (normal control, diabetic control, T. tetraptera treated STZ induced diabetic rats at 150 mg/kg b. w. and T. tetraptera treated STZ-diabetic rats at 300 mg/kg b. w.) were used. Serum and liver alanine and aspartate transaminases (ALT and AST), alkaline phosphatase (ALP), gamma glutamyl transferase (γGT) activities and protein concentration were assessed. Also, serum albumins, globulins, total and direct bilirubin concentrations were measured. STZ induced diabetes significantly (P<0.05) increased serum ALT, AST and ALP activities, while treatment of diabetic rats with T. tetraptera reduced the activities of these enzymes. T. tetraptera caused significant (P<0.05) increases in serum γGT, total and direct bilirubin levels, especially at the higher dose (300mg/kg body weight). While the treatment of STZ induced diabetic rats with the extract of T. tetraptera ameliorated hepatocellular damage, at the higher dose of 300mg/kg body weight, T. tetraptera treatment may cause bile duct obstruction. The use of this plant in the treatment of diabetes or other diseases should therefore be monitored with respect to hepato-biliary toxicity.

Keywords: Tetrapleura tetraptera, STZ diabetes, Liver function, Toxicity, Medicinal plants